Il-2 Receptors--structure And Function
Il-2受体--结构与功能
基本信息
- 批准号:6690574
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:JAK kinase T lymphocyte biological signal transduction cellular immunity cytokine cytokine receptors gene mutation gene targeting human tissue interleukin 2 laboratory mouse leukocyte activation /transformation lymphocyte proliferation protein structure function protein tyrosine kinase receptor expression severe combined immunodeficiency
项目摘要
The human IL-2 receptor and related cytokine receptor systems are being studied to clarify the T cell immune response in normal, neoplastic, and immunodeficient states. Following T-cell activation by antigen, the magnitude and duration of the T-cell immune response is determined by the amount of IL-2 produced, levels of receptors expressed, and time course of each event. The IL-2 receptor contains three chains, IL-2Ra, IL-2Rb, and gc. Dr. Leonard cloned IL-2Ra in 1984, his group discovered IL-2Rb in 1986, and reported in 1993 that mutation of the gc chain results in X-linked severe combined immunodeficiency (XSCID, which has a T-B+NK- phenotype) in humans; in 1995 that mutations of the gc-associated kinase, Jak3, result in an autosomal recessive form of SCID indistinguishable from XSCID; and in 1998 that T-B+NK+ SCID results from mutations in the IL7R gene. Based on work in this lab and others, gc was shown to be shared by the receptors for IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Work on the identification of genes induced or repressed by IL-2 and related cytokines has continued and some of these are being characterized. A study on IL-2-mediated repression of IL-7 receptor alpha chain expression was accepted, a finding with potential major implications in understanding how IL-2 can promote cell death as well as repression. The mechanism of IL-7-mediated repression depends on PI 3-kinase and Akt. Other aspects of IL-2 signaling, particularly IL-2-induced serine phosphorylation are being studied, and a major serine phosphorylation site of Stat5a was identified and a manuscript was accepted for publication. Interesting, this phosphorylation did not exert a positive effect as has been found for other STAT proteins; instead, if anything, the effect could be negative. Having reported the previous year the cDNA cloning of a novel type I cytokine receptor protein which was demonstrated to be the receptor for thymic stromal lymphopoietin (TSLP), the group has worked to create a TSLPR KO mouse. The cloning of another novel cytokine receptor, now denoted as the IL-21 receptor, was previously published, creating a new field. It was previously shown that the IL-21 receptor was restricted to lymphoid cells, with expression on T-cells, NK-cells, and B-cells and that the receptor utilized the Jak-STAT pathway. In the past year, major advances were made in studying the effect of this protein in vivo, demonstrating that it plays a criical role in immunoglobulin biosynthesis. Its function in vivo is being further studied. Overall, these studies help to aspects of signaling by IL-2 and related cytokines. These findings have relevance to immunodeficiency and the control of T-cell growth.
人IL-2受体和相关的细胞因子受体系统正在研究中,以澄清正常,肿瘤和免疫缺陷状态下的T细胞免疫应答。在T细胞被抗原激活后,T细胞免疫应答的幅度和持续时间由产生的IL-2的量、表达的受体水平和每个事件的时间过程决定。IL-2受体含有三条链,IL-2 Ra、IL-2 Rb和gc。伦纳德博士于1984年克隆了IL-2 Ra,他的小组于1986年发现了IL-2 Rb,并于1993年报道了GC链突变导致X连锁严重联合免疫缺陷在1995年,GC相关激酶Jak 3的突变导致与XSCID无法区分的常染色体隐性形式的SCID;在1998年,T-B+NK+ SCID是由IL 7 R基因突变引起的。基于本实验室和其他实验室的工作,已证明IL-2、IL-4、IL-7、IL-9、IL-15和IL-21的受体共享gc。鉴定IL-2和相关细胞因子诱导或抑制的基因的工作仍在继续,其中一些正在进行表征。一项关于IL-2介导的IL-7受体α链表达抑制的研究被接受,这一发现对理解IL-2如何促进细胞死亡以及抑制具有潜在的重要意义。IL-7介导的抑制机制依赖于PI 3-激酶和Akt。正在研究IL-2信号传导的其他方面,特别是IL-2诱导的丝氨酸磷酸化,并且鉴定了Stat 5a的主要丝氨酸磷酸化位点,并接受了手稿以供出版。有趣的是,这种磷酸化并没有像其他STAT蛋白那样产生积极的影响;相反,如果有的话,这种影响可能是负面的。在前一年报道了一种新的I型细胞因子受体蛋白的cDNA克隆,该蛋白被证明是胸腺基质淋巴细胞生成素(TSLP)的受体,该小组已经致力于创建TSLPR KO小鼠。另一种新的细胞因子受体的克隆,现在被称为IL-21受体,以前发表过,创造了一个新的领域。先前显示IL-21受体限于淋巴样细胞,在T细胞、NK细胞和B细胞上表达,并且该受体利用Jak-STAT途径。在过去的一年中,在研究这种蛋白在体内的作用方面取得了重大进展,证明它在免疫球蛋白的生物合成中起着关键作用。其在体内的功能正在进一步研究中。总的来说,这些研究有助于IL-2和相关细胞因子的信号转导方面。这些发现与免疫缺陷和T细胞生长的控制有关。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Warren J Leonard其他文献
The role of Stat5a and Stat5b in signaling by IL-2 family cytokines
Stat5a 和 Stat5b 在白细胞介素 2 家族细胞因子信号传导中的作用
- DOI:
10.1038/sj.onc.1203523 - 发表时间:
2000-05-25 - 期刊:
- 影响因子:7.300
- 作者:
Jian-Xin Lin;Warren J Leonard - 通讯作者:
Warren J Leonard
Priming for T helper type 2 differentiation by interleukin 2–mediated induction of interleukin 4 receptor α-chain expression
白细胞介素 2 介导的白细胞介素 4 受体α链表达诱导对 T 辅助 2 型分化的启动
- DOI:
10.1038/ni.1656 - 发表时间:
2008-09-28 - 期刊:
- 影响因子:27.600
- 作者:
Wei Liao;Dustin E Schones;Jangsuk Oh;Yongzhi Cui;Kairong Cui;Tae-Young Roh;Keji Zhao;Warren J Leonard - 通讯作者:
Warren J Leonard
JAK3 inhibition—is it sufficient?
JAK3 抑制——这就足够了吗?
- DOI:
10.1038/nchembio.2066 - 发表时间:
2016-04-19 - 期刊:
- 影响因子:13.700
- 作者:
Warren J Leonard;Suman Mitra;Jian-Xin Lin - 通讯作者:
Jian-Xin Lin
Warren J Leonard的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Warren J Leonard', 18)}}的其他基金
IL-2 Family Cytokines and Receptors-- Mechanisms of Regulation & Action
IL-2 家族细胞因子和受体——调节机制
- 批准号:
8746596 - 财政年份:
- 资助金额:
-- - 项目类别:
IL-2 Family Cytokines and their Receptors-- Biology of the IL-21 system
IL-2 家族细胞因子及其受体——IL-21 系统的生物学
- 批准号:
8939804 - 财政年份:
- 资助金额:
-- - 项目类别:
IL-2 Family Cytokines and their Receptors-- Biology of the IL-21 system
IL-2 家族细胞因子及其受体——IL-21 系统的生物学
- 批准号:
8344812 - 财政年份:
- 资助金额:
-- - 项目类别:
IL-2 Family Cytokines and their Receptors-- Molecular Regulation via GABP
IL-2 家族细胞因子及其受体——通过 GABP 进行分子调控
- 批准号:
7735035 - 财政年份:
- 资助金额:
-- - 项目类别:
IL-2 Family Cytokines and their Receptors-- Biology of the IL-2 system
IL-2 家族细胞因子及其受体——IL-2 系统的生物学
- 批准号:
10262667 - 财政年份:
- 资助金额:
-- - 项目类别:
IL-2 Family Cytokines and Receptors-- Mechanisms of Regulation & Action
IL-2 家族细胞因子和受体——调节机制
- 批准号:
10262668 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Modulation of T lymphocyte Activation by Ã2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
RGPIN-2019-06980 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10581488 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574979-2022 - 财政年份:2022
- 资助金额:
-- - 项目类别:
University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
- 批准号:
10332251 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574984-2022 - 财政年份:2022
- 资助金额:
-- - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574985-2022 - 财政年份:2022
- 资助金额:
-- - 项目类别:
University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by Ã2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
- 批准号:
574978-2022 - 财政年份:2022
- 资助金额:
-- - 项目类别:
University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
- 批准号:
444149 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
- 批准号:
RGPIN-2019-06980 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




